Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Protein Purification
  5. Protease Inhibitors and Phosphatase Inhibitors
  6. MilliporeSigma™ Calbiochem™ Roscovitine

MilliporeSigma™ Calbiochem™ Roscovitine

Catalog No. p-7060150 Shop All MilliporeSigma Products
Click to view available options
Quantity:
1 mg
5 mg

Description

A potent, reversible, and selective inhibitor of Cdks that exhibits about 10-fold greater efficacy towards p34-cdk1 and p33-cdk2 and 20-fold greater efficacy towards p33-cdk5 relative to Olomoucine.

Inhibits p34cdk1/cyclin B (IC50 = 650 nM), p33cdk2/cyclin A (IC50 = 700 nM), p33cdk2/cyclin E (IC50 = 700 nM), and p33cdk5/p35 (IC50 = 200 nM) by competing for the ATP binding domain of the kinases. Exhibits reduced sensitivity towards related kinases including ERK1 and ERK2 (IC50 = 34μM and 14μM, respectively). Roscovitine does not significantly affect the activity of other protein kinases even at 100μM, including p34cdk4/cyclin D1 and p40cdk6/cyclin D2. Compared to olomoucine, roscovitine displays increased anti-mitotic activity at the G1/S and G2/M phases of the cell cycle. A 50mm (5mg/282μl) solution of Roscovitine (Cat. No. 557364) in DMSO is also available.
TRUSTED_SUSTAINABILITY

Specifications

Color White to Off-white
Target Proteins p34cdk1/cyclin B
CAS 186692-46-6
Molecular Formula C19H26N6O
Formula Weight 354.5g/mol
Solubility DMSO
Form Solid
Quantity 5 mg
Purity 95% by HPLC
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.